The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: PRESTIGE—Primary retroperitoneal lymph node dissection (RPLND) for clinical stage II (CSII) testicular germ cell tumour (TGCT) and its impact on health-related quality of life (HRQoL) compared to chemotherapy or radiotherapy.
 
Ciara Conduit
Honoraria - AstraZeneca
 
Jeremy Howard Lewin
Consulting or Advisory Role - Bayer (Inst)
 
Elizabeth Chien Hern Liow
Travel, Accommodations, Expenses - Pfizer
 
Haryana M. Dhillon
Honoraria - BMS (Inst)
Consulting or Advisory Role - Janssen Oncology (Inst)
 
Wei Hong
No Relationships to Disclose
 
Richard De Abreu Lourenço
Consulting or Advisory Role - Vifor Pharma (I)
 
Nathan Lawrentschuk
Honoraria - Device technologies
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Urotech
 
Benjamin Thomas
No Relationships to Disclose
 
Peter S. Grimison
Research Funding - ASLAN Pharmaceuticals (Inst); Boston Biomedical (Inst); Daiichi Sankyo Europe GmbH (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai (Inst); Epizyme (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); Medimmune; MSD (Inst); Pfizer (Inst); Pfizer (Inst); QED Therapeutics (Inst); Specialised Therapeutics (Inst); Tilray (Inst)
 
Nariman Ahmadi
Stock and Other Ownership Interests - Ramsay Health Care
 
Shomik Sengupta
Honoraria - AstraZeneca (Inst); Mundipharma (Inst)
 
Ben Tran
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Janssen-Cilag; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; IQvia; Janssen-Cilag; MSD Oncology; Novartis; Pfizer/EMD Serono; Pfizer/EMD Serono; Roche Molecular Diagnostics; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb; Genentech (Inst); Ipsen; Janssen-Cilag (Inst); Merck Sharp & Dohme; Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma